Gas chromatography nitrogen phosphorous detection (GC-NPD) assay of tofisopam in human plasma for pharmacokinetic evaluation

Maria Tóth, Andrea Bereczki, Sándor Drabant, Katalin Balogh Nemes, Bálint Varga, Gyula Grézal, Judit Tömlo, Géza Lakner, I. Klebovich

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Tofisopam (1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiaz epine) has been shown to be an effective anxiolytic agent in the wide-ranging clinical practice. A high sensitive gas chromatography nitrogen phosphorous detection (GC-NPD) bioanalytical method was developed and validated for the purpose of pharmacokinetic study of tofisopam. A liquid-liquid extraction method was used for the sample preparation. The mean recovery for tofisopam was 69.8% and the inter- and intra-day precision values were well below the 15% limit established for bioanalytical methods. A similar compound, girizopam was used as internal standard. The assay was linear in the 5-500 ng/ml range corresponding to therapeutically relevant plasma levels. The concentrations of the compound were measured in the plasma samples of 12 healthy male volunteers and the pharmacokinetic parameters were determined from the plasma concentration-time data. A rapid absorption and distribution, relatively short biological half-life and considerable inter-individual variation in the plasma concentration levels of parent compound were the main characteristics of the pharmacokinetics of tofisopam. According to these results, the new (GC-NPD) bioanalytical method proved to be capable of measuring concentration of tofisopam in human plasma and was successfully applied in a single dose pharmacokinetic study.

Original languageEnglish
Pages (from-to)1354-1359
Number of pages6
JournalJournal of Pharmaceutical and Biomedical Analysis
Volume41
Issue number4
DOIs
Publication statusPublished - Jun 16 2006

Fingerprint

Plasma (human)
Pharmacokinetics
Gas chromatography
Gas Chromatography
Assays
Nitrogen
Plasmas
Liquid-Liquid Extraction
Anti-Anxiety Agents
Liquids
Half-Life
Healthy Volunteers
tofisopam
Recovery

Keywords

  • Gas chromatography nitrogen phosphorous detection (GC-NPD)
  • Pharmacokinetics
  • Single dose clinical study
  • Tofisopam

ASJC Scopus subject areas

  • Analytical Chemistry
  • Pharmaceutical Science

Cite this

Gas chromatography nitrogen phosphorous detection (GC-NPD) assay of tofisopam in human plasma for pharmacokinetic evaluation. / Tóth, Maria; Bereczki, Andrea; Drabant, Sándor; Nemes, Katalin Balogh; Varga, Bálint; Grézal, Gyula; Tömlo, Judit; Lakner, Géza; Klebovich, I.

In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 41, No. 4, 16.06.2006, p. 1354-1359.

Research output: Contribution to journalArticle

Tóth, Maria ; Bereczki, Andrea ; Drabant, Sándor ; Nemes, Katalin Balogh ; Varga, Bálint ; Grézal, Gyula ; Tömlo, Judit ; Lakner, Géza ; Klebovich, I. / Gas chromatography nitrogen phosphorous detection (GC-NPD) assay of tofisopam in human plasma for pharmacokinetic evaluation. In: Journal of Pharmaceutical and Biomedical Analysis. 2006 ; Vol. 41, No. 4. pp. 1354-1359.
@article{d5bfb70d42514b4181ec3a2fc1b8d925,
title = "Gas chromatography nitrogen phosphorous detection (GC-NPD) assay of tofisopam in human plasma for pharmacokinetic evaluation",
abstract = "Tofisopam (1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiaz epine) has been shown to be an effective anxiolytic agent in the wide-ranging clinical practice. A high sensitive gas chromatography nitrogen phosphorous detection (GC-NPD) bioanalytical method was developed and validated for the purpose of pharmacokinetic study of tofisopam. A liquid-liquid extraction method was used for the sample preparation. The mean recovery for tofisopam was 69.8{\%} and the inter- and intra-day precision values were well below the 15{\%} limit established for bioanalytical methods. A similar compound, girizopam was used as internal standard. The assay was linear in the 5-500 ng/ml range corresponding to therapeutically relevant plasma levels. The concentrations of the compound were measured in the plasma samples of 12 healthy male volunteers and the pharmacokinetic parameters were determined from the plasma concentration-time data. A rapid absorption and distribution, relatively short biological half-life and considerable inter-individual variation in the plasma concentration levels of parent compound were the main characteristics of the pharmacokinetics of tofisopam. According to these results, the new (GC-NPD) bioanalytical method proved to be capable of measuring concentration of tofisopam in human plasma and was successfully applied in a single dose pharmacokinetic study.",
keywords = "Gas chromatography nitrogen phosphorous detection (GC-NPD), Pharmacokinetics, Single dose clinical study, Tofisopam",
author = "Maria T{\'o}th and Andrea Bereczki and S{\'a}ndor Drabant and Nemes, {Katalin Balogh} and B{\'a}lint Varga and Gyula Gr{\'e}zal and Judit T{\"o}mlo and G{\'e}za Lakner and I. Klebovich",
year = "2006",
month = "6",
day = "16",
doi = "10.1016/j.jpba.2006.03.033",
language = "English",
volume = "41",
pages = "1354--1359",
journal = "Journal of Pharmaceutical and Biomedical Analysis",
issn = "0731-7085",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Gas chromatography nitrogen phosphorous detection (GC-NPD) assay of tofisopam in human plasma for pharmacokinetic evaluation

AU - Tóth, Maria

AU - Bereczki, Andrea

AU - Drabant, Sándor

AU - Nemes, Katalin Balogh

AU - Varga, Bálint

AU - Grézal, Gyula

AU - Tömlo, Judit

AU - Lakner, Géza

AU - Klebovich, I.

PY - 2006/6/16

Y1 - 2006/6/16

N2 - Tofisopam (1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiaz epine) has been shown to be an effective anxiolytic agent in the wide-ranging clinical practice. A high sensitive gas chromatography nitrogen phosphorous detection (GC-NPD) bioanalytical method was developed and validated for the purpose of pharmacokinetic study of tofisopam. A liquid-liquid extraction method was used for the sample preparation. The mean recovery for tofisopam was 69.8% and the inter- and intra-day precision values were well below the 15% limit established for bioanalytical methods. A similar compound, girizopam was used as internal standard. The assay was linear in the 5-500 ng/ml range corresponding to therapeutically relevant plasma levels. The concentrations of the compound were measured in the plasma samples of 12 healthy male volunteers and the pharmacokinetic parameters were determined from the plasma concentration-time data. A rapid absorption and distribution, relatively short biological half-life and considerable inter-individual variation in the plasma concentration levels of parent compound were the main characteristics of the pharmacokinetics of tofisopam. According to these results, the new (GC-NPD) bioanalytical method proved to be capable of measuring concentration of tofisopam in human plasma and was successfully applied in a single dose pharmacokinetic study.

AB - Tofisopam (1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiaz epine) has been shown to be an effective anxiolytic agent in the wide-ranging clinical practice. A high sensitive gas chromatography nitrogen phosphorous detection (GC-NPD) bioanalytical method was developed and validated for the purpose of pharmacokinetic study of tofisopam. A liquid-liquid extraction method was used for the sample preparation. The mean recovery for tofisopam was 69.8% and the inter- and intra-day precision values were well below the 15% limit established for bioanalytical methods. A similar compound, girizopam was used as internal standard. The assay was linear in the 5-500 ng/ml range corresponding to therapeutically relevant plasma levels. The concentrations of the compound were measured in the plasma samples of 12 healthy male volunteers and the pharmacokinetic parameters were determined from the plasma concentration-time data. A rapid absorption and distribution, relatively short biological half-life and considerable inter-individual variation in the plasma concentration levels of parent compound were the main characteristics of the pharmacokinetics of tofisopam. According to these results, the new (GC-NPD) bioanalytical method proved to be capable of measuring concentration of tofisopam in human plasma and was successfully applied in a single dose pharmacokinetic study.

KW - Gas chromatography nitrogen phosphorous detection (GC-NPD)

KW - Pharmacokinetics

KW - Single dose clinical study

KW - Tofisopam

UR - http://www.scopus.com/inward/record.url?scp=33746608163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746608163&partnerID=8YFLogxK

U2 - 10.1016/j.jpba.2006.03.033

DO - 10.1016/j.jpba.2006.03.033

M3 - Article

VL - 41

SP - 1354

EP - 1359

JO - Journal of Pharmaceutical and Biomedical Analysis

JF - Journal of Pharmaceutical and Biomedical Analysis

SN - 0731-7085

IS - 4

ER -